HomeInsightsStock Comparison

Advanced Enzyme Technologies Ltd vs Mankind Pharma Ltd Stock Comparison

Advanced Enzyme Technologies Ltd vs Mankind Pharma Ltd Stock Comparison

Last Updated on: Jun 03, 2025

Key Highlights

  • The Latest Trading Price of Advanced Enzyme Technologies Ltd is ₹ 304.5 as of 03 Jun 15:30.
  • The P/E Ratio of Advanced Enzyme Technologies Ltd changed from 12.4 on March 2020 to 29.1 on March 2024 . This represents a CAGR of 18.60% over 5 yearsThe P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 48.1 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Advanced Enzyme Technologies Ltd changed from ₹ 1598 crore on March 2020 to ₹ 3885 crore on March 2024 . This represents a CAGR of 19.44% over 5 yearsThe Market Cap of Mankind Pharma Ltd changed from ₹ 92029 crore on March 2024 to ₹ 92029 crore on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Advanced Enzyme Technologies Ltd for the Mar '25 is ₹ 175.92 crore as compare to the Dec '24 revenue of ₹ 176.8 crore. This represent the decline of -0.5% The revenue of Mankind Pharma Ltd for the Mar '25 is ₹ 3333 crore as compare to the Dec '24 revenue of ₹ 3285 crore. This represent the growth of 1.43%.
  • The ebitda of Advanced Enzyme Technologies Ltd for the Mar '25 is ₹ 54.35 crore as compare to the Dec '24 ebitda of ₹ 62.94 crore. This represent the decline of -13.65% The ebitda of Mankind Pharma Ltd for the Mar '25 is ₹ 932.5 crore as compare to the Dec '24 ebitda of ₹ 903.08 crore. This represent the growth of 3.26%.
  • The net profit of Advanced Enzyme Technologies Ltd changed from ₹ 29.38 crore to ₹ 26.73 crore over 8 quarters. This represents a CAGR of -4.62% The net profit of Mankind Pharma Ltd changed from ₹ 494.19 crore to ₹ 424.65 crore over 8 quarters. This represents a CAGR of -7.30% .
  • The Dividend Payout of Advanced Enzyme Technologies Ltd changed from 11.56 % on March 2020 to 52.76 % on March 2024 . This represents a CAGR of 35.48% over 5 yearsThe Dividend Payout of Mankind Pharma Ltd changed from 31.56 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Advanced Enzyme Technologies Ltd

  • Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing and sale of enzymes.
  • Advanced Enzyme Technologies Limited was incorporated, as a Private Company on March 15, 1989 as 'Advanced Biochemicals Private Limited' in Maharashtra.
  • The Company thereafter, got converted into a Public Company and the name of the Company changed to Advanced Biochemicals Limited on May 28, 1992.
  • Again, the name was changed to Advanced Enzyme Technologies Limited and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Mumbai on August 19, 2005. In 2011, the company took over Cal-India Foods International, giving the company direct presence in USA. In 2012, the company took over Advanced Supplementary Technologies Corporation for consolidating its presence in USA.

About Mankind Pharma Ltd

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

Advanced Enzyme Technologies Ltd News Hub

News

Board of Advanced Enzyme Techs. recommends final dividend

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting...

Read more

13 May 2025 14:29

News

Board of Advanced Enzyme Techs. recommends interim dividend

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting...

Read more

13 May 2025 14:29

News

Advanced Enzyme Techs. to convene AGM

Advanced Enzyme Techs. announced that the 36th Annual General Meeting(AGM) of the company ...

Read more

13 May 2025 17:04

News

Advanced Enzyme Techs. to declare Quarterly Results

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 ...

Read more

08 May 2025 11:18

News

Advanced Enzyme Techs. to declare Quarterly Results

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 ...

Read more

07 May 2025 11:26

News

Advanced Enzyme Technologies allots 500 equity shares under ESOS

Advanced Enzyme Technologies has allotted 500 equity shares under ESOS on 19 March 2025. C...

Read more

19 Mar 2025 15:59

Mankind Pharma Ltd News Hub

News

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs ...

Read more

23 May 2025 13:35

News

Mankind Pharma slides after Q4 PAT drops 11% YoY to Rs 421 cr

However, revenue from operations increased 27.19% year-on-year (YoY) to Rs 3,079.37 crore ...

Read more

22 May 2025 15:37

News

Board of Mankind Pharma approves incorporation of WoS in Sri Lanka

The Board of Mankind Pharma at its meeting held on 21 May 2025 has approved the incorporat...

Read more

21 May 2025 18:52

News

Mankind Pharma allots 92,512 equity shares under ESOP

Mankind Pharma has allotted 92,512 equity shares under ESOP on 21 May 2025. Consequent to ...

Read more

21 May 2025 14:16

News

Mankind Pharma to discuss results

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 21 May 2025...

Read more

09 May 2025 10:55

News

Mankind Pharma slides after Q3 PAT slips 16% YoY to Rs 380 cr

However, revenue from operations increased 23.9% year on year (YoY) to Rs 3,230 crore in t...

Read more

24 Jan 2025 12:12

SWOT Analysis Of Mankind Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Advanced Enzyme Technologies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Mankind Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Advanced Enzyme Technologies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Advanced Enzyme Technologies Ltd and Mankind Pharma Ltd

Which company has a larger market capitalization, Advanced Enzyme Technologies Ltd or Mankind Pharma Ltd?

Market cap of Advanced Enzyme Technologies Ltd is 3,408 Cr while Market cap of Mankind Pharma Ltd is 99,618 Cr

What are the key factors driving the stock performance of Advanced Enzyme Technologies Ltd and Mankind Pharma Ltd?

The stock performance of Advanced Enzyme Technologies Ltd and Mankind Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Advanced Enzyme Technologies Ltd and Mankind Pharma Ltd?

As of June 3, 2025, the Advanced Enzyme Technologies Ltd stock price is INR ₹304.65. On the other hand, Mankind Pharma Ltd stock price is INR ₹2414.0.

How do dividend payouts of Advanced Enzyme Technologies Ltd and Mankind Pharma Ltd compare?

To compare the dividend payouts of Advanced Enzyme Technologies Ltd and Mankind Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions